- May 13, 2022
- 1 min read

NIH Research to Address the Real-Life Challenges of Opioid Crisis

Atlanta, GA | May 2022

https://directorsblog.nih.gov/2022/05/10/rx-and-illicit-drug-summit-a-conversation-on-helping-people-and-families-in-need/

Recent Posts

See All

CS Inc. presents at 2024 Rx and Illicit Drug Summit.

Atlanta, GA | April 1, 2024 Clear Scientific presented a poster titled: Hope in Methamphetamine Addiction and Overdose, Authors: P. Oliver, C. Leggett, M. Vara, A. Mager, X. Li, M. Zakin, S. Shetty,

Clear Scientific Awarded up to $15M from NIDA for Continued Development of Fentanyl Antidote.

Cambridge, MA | Nov 2023 Clear Scientific, a clinical-stage biopharmaceutical company, today announced an award from the National Institute on Drug Abuse (NIDA) of the NIH, with a total potential val

Clear Scientific Awarded $12M NIDA Grant for Continued Development of Meth Antidote.

Cambridge, MA | Nov 2023 Clear Scientific, a clinical-stage biopharmaceutical company, today announced a $12M award from the National Institute on Drug Abuse of the NIH to support development of CS-1

NIH Research to Address the Real-Life Challenges of Opioid Crisis

Recent Posts

Contact Us